+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
[P.3.f.007] Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics
Home
Publications
[P.3.f.007] Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics
Back Home
[P.3.f.007] Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics
2013 Eur. Neuropsychopharmacol
Vataire, A.L. | Ferchichi, S. | Desroziers, K. | Cadi-Soussi, N. | Murthy, V. | Toumi, M. |
Volume: 25, Issue: Suppl 2, Pages: S495,
Antipsychotic Agents, Cardiovascular Diseases, database analysis, Disease, Risk, Schizophrenia,
